Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-03-12FDA Approved: METFORMIN HCL — Original Application (TIME CAP LABORATORIES, INC)
FDA approved metformin hydrochloride as an original generic application by Time Cap Laboratories, Inc. for treatment of type 2 diabetes mell…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Integrating Depression Services Into DM Management [NA]
A completed clinical trial investigated integrating depression services into the management of Type 2 diabetes, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM [Phase 3]
Phase 3 studies evaluated linagliptin as monotherapy and in combination for type 2 diabetes mellitus; results from the completed trial were …
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of combining saxagliptin with metformin in adults with type 2 diabetes; results were po…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Basal Insulin for Type 2 Diabetes Patients Treated in Outpatient Clalit Clinics
A Sanofi-sponsored trial evaluating basal insulin in outpatient Type 2 diabetes patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Weight Loss Maintenance (WLM) [NA]
This clinical trial update reports a completed study on Weight Loss Maintenance (WLM) sponsored by Duke University, focusing on obesity and …
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT) [NA]
A pediatric trial evaluating atorvastatin in children with Type 1 or Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)
A postmarketing safety study of JANUMET (sitagliptin phosphate/metformin hydrochloride) for type 2 diabetes was terminated and results were …
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Aspirin Dosing in Diabetic Patients [Phase 4]
A Phase 4 trial update evaluating aspirin dosing in patients with type 2 diabetes mellitus and coronary artery disease; results have been po…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study [Phase 4]
Phase 4 HERMES pilot study evaluating inflammatory mRNA expression in macrophages and endothelial function with short-acting human insulin a…
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: Effects of Exercise on sRAGE Levels and Cardiometabolic Risk Factors [NA]
A completed clinical trial from Korea University evaluating the effects of exercise on sRAGE levels and cardiometabolic risk factors in peop…
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone [Phase 3]
A Phase 3 trial evaluating dapagliflozin as monotherapy in type 2 diabetes patients inadequately controlled with diet and exercise has been …
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy of pioglitazone on macrovascular outcomes in patients with Type 2 diabetes; the study is completed.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin [Phase 2]
Phase 2 trial results evaluating pioglitazone's effect on microcirculation in insulin-treated patients with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease [Phase 3]
Phase 3 trial comparing pioglitazone to glyburide in adults with type 2 diabetes mellitus and mild cardiac disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of combining pioglitazone with azilsartan in adults with Type 2 diabetes mellitus has com…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure [Phase 3]
Phase 3 safety comparison trial comparing pioglitazone and glyburide in adults with type 2 diabetes mellitus and mild to moderate congestive…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. [Phase 4]
Phase 4 clinical trial evaluating triglyceride changes in type 2 diabetes patients after conversion from rosiglitazone to pioglitazone has b…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. [Phase 3]
This is a completed Phase 3 trial evaluating whether pioglitazone plus glimepiride slows progression of atherosclerotic disease in people wi…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia [Phase 3]
Phase 3 trial comparing pioglitazone versus rosiglitazone in adults with Type 2 diabetes mellitus and dyslipidemia; the study status is comp…
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 trial evaluating TAK-559 in combination with metformin for type 2 diabetes mellitus was terminated.
-
FDA approval · 2012-02-27FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References
This clinical trial update assesses noninvasive glucose measurements and compares them to finger-prick glucose references in people with Typ…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: Retrospective Study: Hip Fractures in Diabetic Patients
A retrospective study examining hip fracture outcomes in patients with type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 [Phase 1]
Phase 1 clinical trial update assessing lixisenatide for restoration of insulin release in adults with type 2 diabetes.